Unlocking the mystery of preexisting drug resistance: Study sheds light on cancer evolution
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
The evolution of resistance to diseases, from infectious illnesses to cancers, poses a formidable challenge.
Jul 15, 2024
0
19
A study led by researchers at Brighton and Sussex Medical School (BSMS) has unveiled an approach to predicting the effectiveness of treatments for patients with diffuse large B-cell lymphoma (DLBCL), a common form of blood ...
Jul 15, 2024
0
18
Women who carry a particular form of a pain gene are more likely to respond well to a common medication used to treat long-term discomfort, research shows.
Jul 15, 2024
0
45
Over 700,000 people in the UK have glaucoma and it is the leading cause of irreversible blindness worldwide. The condition occurs when the cells in the eye that help you see (called retinal ganglion cells) start to die.
Jul 12, 2024
0
11
Immunotherapy can be a highly effective treatment for non-small cell lung cancer (NSCLC), but some patients are resistant to the therapy or develop intolerable side effects.
Jul 12, 2024
0
59
Google searches for "NSW scabies outbreak" have spiked over recent days in light of an outbreak of the contagious skin condition in New South Wales.
23 minutes ago
0
0
Most tumors release various signaling molecules to support their incessant growth, invasion, and metastasis. Some of these molecules, known as tumor angiogenic factors (TAF), are able to stimulate the formation of new blood ...
Aug 9, 2024
0
0
Chronic venous insufficiency (CVI), which impacts more than 25 million people, includes varicose and spider veins. They occur when the veins become damaged and can't work as they should.
Aug 8, 2024
0
0
Over the past 30 years, the success rate of pediatric cancer treatments has improved dramatically. It is now above 80%—and even higher for some cancers.
Aug 8, 2024
0
0
Using zebrafish "avatars," an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior, Mayra Martínez-López—a former Ph.D. student at the lab ...
Aug 8, 2024
0
13